More on Iridex v Synergetics
On March 9, 2007, the federal district court had granted in part Iridex's motion for summary judgment of validity, the company said. The court also concluded that the undisputed evidence showed that the Laserscope patent did not contain all of the elements of the patent in suit, thereby making Iridex's patent not invalid for anticipation.
A jury trial is set to start on April 16, Iridex, which provides therapeutic-based laser systems, said in a statement.
The jury will decide on the remaining issues in its patent infringement suit against surgical equipment maker Synergetics, the company said.
Iridex said the jury will decide the amount of damages caused by Synergetics' infringement, whether the infringement was willful, and whether Iridex's patent is invalid for obviousness.
0 Comments:
Post a Comment
<< Home